Prognostic value of H-MLH1 after adjusting for RPA class in GBM patients.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Frontiers in Bioscience

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2741/E321PMID 21622124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 2007 WHO classification of tumors of the central nervous system – what has changed?

  2008cited by this paper
• Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma

  2008cited by this paper
• Targeted Modulation of MGMT: Clinical Implications

  2006cited by this paper
• MGMT gene silencing and benefit from temozolomide in glioblastoma.

  2005cited by this paper
• Promoter Hypermethylation of Mismatch Repair Gene hMLH1 Predicts the Clinical Response of Malignant Astrocytomas to Nitrosourea

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• DNA repair inhibition: a selective tumour targeting strategy.

  2005influential reference
• The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer.

  2005cited by this paper
• Methylation profiling of the DNA repair genes in glioblastoma multiforme and its clinical relevance.

  2004cited by this paper
• Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide

  2004cited by this paper
• ATM-Mediated Stabilization of hMutL DNA Mismatch Repair Proteins Augments p53 Activation during DNA Damage

  2004cited by this paper
• Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas

  2004cited by this paper
• Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.

  2004influential reference
• DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.

  2004cited by this paper
• The p38 Mitogen-Activated Protein Kinase Pathway Links the DNA Mismatch Repair System to the G2 Checkpoint and to Resistance to Chemotherapeutic DNA-Methylating Agents

  2003cited by this paper
• Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

  2002cited by this paper
• Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study Groups

  2002influential reference
• Genomic integrity and the repair of double-strand DNA breaks.

  2001cited by this paper
• Identification of a p53 Response Element in the Promoter Region of the hMSH2 Gene Required for Expression in A2780 Ovarian Cancer Cells*

  2001cited by this paper
• Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea.

  2001influential reference
• The challenge of p53 as prognostic and predictive factor in gliomas.

  2000cited by this paper
• Defining the Roles of Nucleotide Excision Repair and Recombination in the Repair of DNA Interstrand Cross-Links in Mammalian Cells

  2000influential reference
• Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

  2000cited by this paper
• Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen

  2000influential reference
• Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.

  1999influential reference
• The role of mismatch repair in DNA damage-induced apoptosis.

  1999cited by this paper
• hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage.

  1999cited by this paper
• Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.

  1998cited by this paper
• Involvement of the mismatch repair system in temozolomide-induced apoptosis.

  1998influential reference
• The role of DNA mismatch repair in drug resistance.

  1998cited by this paper
• Excision repair cross-complementing rodent repair deficiency gene 2 expression and chloroethylnitrosourea resistance in human glioma cell lines.

  1998influential reference
• N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells.

  1998cited by this paper
• Initiation of DNA interstrand cross-link repair in humans: the nucleotide excision repair system makes dual incisions 5' to the cross-linked base and removes a 22- to 28-nucleotide-long damage-free strand

  1997cited by this paper
• Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine.

  1996cited by this paper
• Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs

  1996cited by this paper
• Repair‐deficient 3‐methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation‐induced chromosome damage and cell killing.

  1996cited by this paper
• Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry

  1994cited by this paper
• A Correlative Study of p53 Protein Alteration and p53 Gene Mutation in Glioblastoma Multiforme

  1993cited by this paper
• Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

  1993cited by this paper
• Meta‐analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

  1993cited by this paper
• Differences in DNA alkylation products formed in sensitive and resistant human glioma cells treated with N-(2-chloroethyl)-N-nitrosourea.

  1988cited by this paper

• Conch Shell (Turbinella pyrum) Powder: A Potential Marine Biological Source of Calcium and Some Trace Minerals for Growing Crossbred Calves

  2024cites this paper
• Comprehensive pharmacogenomics characterization of temozolomide response in gliomas.

  2021cites this paper
• The Use of Mussel Shell as a Bio-Additive for Poly(Lactic Acid) Based Green Composites

  2021cites this paper
• NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients

  2018cites this paper